Na úvodní stránku ČLS JEP ČESKÁ LÉKAŘSKÁ SPOLEČNOST J. Ev. PURKYNĚ
Časopisy - Článek
Na úvodní stránku ČLS JEP Aktuality O Společnosti O nakladatelském středisku Časopisy Vyhledávání Knihy Supplementa Katalog
 
  Anglicky / English version Čas. Lék. čes., 138, 1999, No. 2, p. 40-46.
 
TREATMENT OF CHILDREN AND ADOLESCENTS WITH NON-HODGKIN´S LYMPHOMA 
(Results based on the NHL Berlin-Frankfurt-Münster 90 protocols)
P. Kavan, E. Kabičková, 1 P. Gajdoš, J. Koutecký, V. Šmelhaus, J. Staňková, 2 K. L. McClain 

Department of pediatric oncology, University hospital Motol, Prague, Czech Republic
1 Institute of public health, Prague, Czech Republic
2 Texas Children´s Cancer Center, Baylor College of Medicine, Houston, TX
 


Abstrakt:

       Background. To determine the feasibility and results of treating children with non-Hodgkin´s lymphomas (NHL)
according to very intensive protocols based on the German Berlin Frankfurt Münster NHL 90 study.
Methods and Results. From 1991 until 1995 eighty two patients less than 18 years of age with NHL were admitted
to our department. Sixty three of them were eligible for the study. The entire group consisted of 43 males and 20
females (ratio 2.1 : 1). Median age was 10 2/12 years. Eleven had stage I disease, 4 stage II, 29 stage III and 19 stage
IV disease. Histologies represented were: large cell lymphoma 22, lymphoblastic lymphoma 19, and Burkitt
lymphoma 10 patients. In 12 cases the immunophenotype was not further classified as to B-cell or T-cell subtype.
Patients were stratified into the therapy groups „B“ or „non B“ according to histopathology, clinical stage and LDH
level. Therapy for the B group consisted of 2, 4 or 6 courses of intensive 5 day pulses of 6 drugs. Patients in the
non B group received the protocol for acute lymphoblastic leukemia including reinduction and CNS irradiation for
advanced stages. At a median follow-up of 35 months the probability of event free survival (pEFS) at 5 years 70%
and overall survival 73% for entire group. For therapy group B pEFS was 76%. The non B therapy group had a pEFS
60% (p = 0.22). There was a significantly better outcome for children classified as stage I and II. There was no
statistical difference between stage III and IV. Treatment results were comparable between NHL subtypes, except
for large cell lymphomas, which did significantly better (pEFS 90%).
Conclusions. The use of protocols based on BFM 90 study in the Czech Republic was feasible. The pEFS are
approximately 10% lower than the German study but comparable to some other studies. Outcome for large cell
lymphomas was excellent. Reduction of treatment related complication and mortality rate as well as more precise
classification are required.


        Klíčová slova: non-Hodgkin lymphoma, children, BFM 90 protocols, treatment.
       

Objednat toto číslo jako - FYZICKÁ OSOBA nebo PODNIKATELSKÝ SUBJEKT

  ZPĚT NA OBSAH  
 
 
| HOME PAGE | KÓDOVÁNÍ ČEŠTINY | ENGLISH VERSION |
©  1998 - 2008 ČESKÁ LÉKAŘSKÁ SPOLEČNOST J. E. PURKYNĚ
Výroba: NT Servis, s.r.o., provozovatel serveru P.E.S. consulting, s.r.o.
WEBMASTER